Heart failure and comorbidities: kidney disease and cancer

EPCCS Annual CV Summit

5' education - Mar. 22, 2019 - Lisbon, Portugal - Peter van der Meer & Monika Hollander

Video navigation menu

What is known about effect of treatment in HF patients with renal dysfunction? 0:36
How to manage patients with fluid overload and renal dysfunction? 1:44
Potential cardiotoxic side-effects of cancer treatment 3:24

Educational information

This video was recorded during the two-day EPCCS CV Summit and aims to give an impression of the presentation given by prof. Van der Meer.

Faculty

Peter van der Meer is Professor of Heart Failure and Translational Cardiology at the University of Groningen and director of the coronary care unit of the University Medical Center Groningen, The Netherlands.

Dr. Monika Hollander - General Practitioner, Julius Center for Health Sciences and Primary Care, Utrecht, The Netherlands

Disclosures

This recording was independently developed under auspices of EPCCS. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of EPCCS. No funding was obtained for the recording of this video.

Read an impression of the presentation of prof. Van der Meer View the slides of the presentation of prof. Van der Meer

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.